Inventor
Barczak Nicholas
US15 patents
⚠️ This page may combine multiple inventors who share the name “Barczak Nicholas”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FORMA THERAPEUTICS INC
9 patentsUS9637453B2May 2, 2017
3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors
FORMA THERAPEUTICS INC51 citations98
US9630922B2Apr 25, 2017
3-spiro-7-hydroxamic acid tetralins as HDAC inhibitors
FORMA THERAPEUTICS INC49 citations98
US10266487B2Apr 23, 2019
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
FORMA THERAPEUTICS INC4 citations84
US9745253B2Aug 29, 2017
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
FORMA THERAPEUTICS INC10 citations84
US10508077B2Dec 17, 2019
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
FORMA THERAPEUTICS INC2 citations73
US10508088B2Dec 17, 2019
Methods using HDAC11 inhibitors
FORMA THERAPEUTICS INC3 citations73
US10370343B2Aug 6, 2019
[6,6] Fused bicyclic HDAC8 inhibitors
FORMA THERAPEUTICS INC2 citations73
US10538496B2Jan 21, 2020
Methods using HDAC11 inhibitors
FORMA THERAPEUTICS INC3 citations72
US10029995B2Jul 24, 2018
[6,6] fused bicyclic HDAC8 inhibitors
FORMA THERAPEUTICS INC3 citations71
VALO HEALTH INC
4 patentsUS11345672B2May 31, 2022
Methods using HDAC11 inhibitors
VALO HEALTH INC2 citations73
US12479807B2Nov 25, 2025
Methods using HDAC11 inhibitors
VALO HEALTH INC0 citations62
US11919839B2Mar 5, 2024
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
VALO HEALTH INC0 citations62
US11414392B2Aug 16, 2022
[6,6] fused bicyclic HDAC8 inhibitors
VALO HEALTH INC0 citations62